At JP Morgan, Mass Spec Vendors Sketch Clinical Proteomics Plans, Highlight Top-selling Systems | GenomeWeb

Several major mass spec vendors took the stage this week at the JP Morgan Healthcare Conference in San Francisco, highlighting strong sales of recent instrument launches and sketching out potential future directions for their businesses.

A number of presentations touched on the continuing rise of clinical mass spec, with Danaher, Agilent, and Bruker discussing efforts to move various systems into the clinic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.